Apoptosis inhibitor 5 (API-5; AAC-11; FIF) is upregulated in human carcinomas in vivo.

Apoptosis inhibitor 5 (API-5) is a 55 kDa nuclear protein with potent anti-apoptotic signaling in tumor cells in vitro. In this study, we analyzed the expression of the API-5 protein in vivo in a broad spectrum of human carcinomas, including those of the colon, lung, liver, kidney, pancreas, stomach and esophagus using tumor tissues obtained during tumor resection. The results showed significant upregulation of API-5 expression in biopsies of lung (23%, n=13) and colorectal tumors (33%, n=27) in comparison with biopsies from the adjacent normal tissue. Colon cancer biopsies were used to study the cell populations with an upregulated level of expression of API-5 more closely. Using a magnetic bead-based selection for the epithelial cell marker EpCAM, we purified epithelial cells from the tumor and control tissues and analyzed these cells for API-5 expression by western immunoblotting. We observed that EpCAM-positive tumor cells expressed API-5 in all three colorectal cancer cases tested, in contrast to the control EpCAM-positive and EpCAM-negative cells isolated from the control or tumor tissues. These data suggest that the expression of the API-5 protein is upregulated in tumor epithelial cells and may serve as a prognostic marker in colorectal cancer.

[1]  M. Bissonnette,et al.  miR‐143 and miR‐145 are downregulated in ulcerative colitis: Putative regulators of inflammation and protooncogenes , 2012, Inflammatory bowel diseases.

[2]  Qinghua Zhou,et al.  Gene expression levels of CSNK1A1 and AAC-11, but not NME1, in tumor tissues as prognostic factors in NSCLC patients. , 2010, Medical science monitor : international medical journal of experimental and clinical research.

[3]  Jean-Luc Poyet,et al.  The antiapoptotic protein AAC‐11 interacts with and regulates Acinus‐mediated DNA fragmentation , 2009, The EMBO journal.

[4]  W. Wilcox,et al.  The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up‐regulated in B cell chronic lymphoid leukemia , 2007, Journal of leukocyte biology.

[5]  Michael F. Clarke,et al.  Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.

[6]  Jun-Yuan Ji,et al.  Functional Identification of Api5 as a Suppressor of E2F-Dependent Apoptosis In Vivo , 2006, PLoS genetics.

[7]  H. Sasaki,et al.  Expression of the antiapoptosis gene, AAC-11, as a prognosis marker in non-small cell lung cancer. , 2001, Lung cancer.

[8]  W. Bickmore,et al.  Large-scale identification of mammalian proteins localized to nuclear sub-compartments. , 2001, Human molecular genetics.

[9]  J. Kim,et al.  AAC-11 Overexpression Induces Invasion and Protects Cervical Cancer Cells from Apoptosis , 2000, Laboratory Investigation.

[10]  B. Ross,et al.  AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal. , 1997, Cancer research.